---

Note: Williams Obstetrics is not in the library's collection. The content below is drawn from Berek & Novak's Gynecology and Creasy & Resnik's Maternal-Fetal Medicine — both authoritative OB/GYN references that cover this topic in equivalent depth.

---

Luteal Phase Defect (LPD) — Definition, Mechanisms, Diagnosis & Management

---

Definition

• Progesterone secretion by the corpus luteum
• Appropriate endometrial secretory transformation permitting embryo implantation
• Corpus luteum support of early pregnancy for the first 7–8 weeks of gestation, until the luteal-placental shift occurs

---

Mechanisms / Etiology

---

Diagnosis

Current consensus (ASRM 2015, reaffirmed 2021): There is no reproducible, pathophysiologically relevant, and clinically practical standard to diagnose luteal phase deficiency and distinguish fertile from infertile women. Similarly, ESHRE does not recommend screening or treating for LPD in women with recurrent pregnancy loss (RPL).

---

Management

1. Progesterone Supplementation

Routes of Administration:

No consensus on superiority of vaginal vs. IM administration.

Timing in ART cycles:

• Progesterone initiated day 0 to day 3 post-retrieval is optimal
• Starting before hCG-triggered retrieval OR delaying until >6 days post-retrieval → lower pregnancy rates
• For vaginal route: delayed start until 48 hours post-retrieval has been advocated (more rapid endometrial advancement)
• Continued until 8–10 weeks of gestation

Non-ART use:

• Intravaginal progesterone may increase pregnancy rates in PCOS women treated with letrozole
• A 2017 systematic review showed benefit for unexplained infertility using vaginal progesterone initiated 0–2 days post-IUI (in cycles using clomiphene ± gonadotropins): 1 live birth per 11 patients treated

2. Treat Underlying Causes

---

Clinical Significance

• LPD is implicated in both infertility and recurrent pregnancy loss (RPL)
• Pregnancy failures may occur near the expected luteal-placental shift (7–9 weeks) if the trophoblast cannot sustain progesterone production after corpus luteum demise
• Impaired decidualization of the endometrium may act as a mechanism of natural selection of human embryos
• Despite its biological plausibility, the clinical entity of LPD remains controversial — no consensus diagnostic standard exists, and empiric treatment with progesterone is the practical approach in clinical settings

---

📚 Complete Medical Textbook Library

---

🦴 Anatomy (8 books)

---

💉 Anesthesiology (3 books)

---

🧬 Biochemistry (3 books)

---

❤️ Cardiology (3 books)

---

🩹 Dermatology (4 books)

---

🧫 Embryology (2 books)

---

🚑 Emergency Medicine (3 books)

---

👂 ENT / Otolaryngology (2 books)

---

👨‍👩‍👧 Family Medicine (3 books)

---

🔬 Gastroenterology (3 books)

---

🔪 General Surgery (4 books)

---

🧬 Genetics (2 books)

---

🔬 Histology (2 books)

---

🛡️ Immunology (3 books)

---

🏥 Internal Medicine (3 books)

---

🧪 Laboratory Medicine (3 books)

---

🦠 Microbiology (3 books)

---

🫘 Nephrology (3 books)

---

🧠 Neurology (5 books)

---

🧬 Neuroscience (3 books)

---

🤰 Obstetrics & Gynecology (2 books)

---

👁️ Ophthalmology (2 books)

---

🦷 Orthopedics (2 books)

---

🔬 Pathology (2 books)

---

👶 Pediatrics (2 books)

---

💊 Pharmacology (3 books)

---

⚡ Physiology (4 books)

---

🧠 Psychiatry (5 books)

---

🫁 Pulmonology (2 books)

---

🩻 Radiology (1 book)

---

🫀 Urology (3 books)

---

---

Luteal Phase Defect — Summary from All Books in the Library

---

📘 1. Berek & Novak's Gynecology

Definition

Mechanisms

Pathophysiology (RPL angle)

• Pregnancy depends on corpus luteum progesterone from ovulation until the luteal-placental shift at 7–9 weeks
• LPD → impaired decidualization → mechanism of natural selection of embryos
• PCOS found in 40–80% of recurrent pregnancy loss (RPL) patients

Diagnosis

Treatment

• Optimal initiation: Day 0–3 post egg retrieval
• Starting before retrieval OR after Day 6 → lower pregnancy rates
• Duration: until 8–10 weeks gestation

• Vaginal progesterone post-IUI (0–2 days): 1 live birth per 11 patients treated (2017 systematic review)
• May increase pregnancy rates in PCOS women on letrozole

---

📗 2. Creasy & Resnik's Maternal-Fetal Medicine

Key Points

• LPD has been formally defined as disorders of inadequate progesterone production or action causing miscarriage or RPL
• Role of progesterone inadequacy as a cause of pregnancy loss remains controversial even after decades of study
• No consensus on method of diagnosis or treatment
• Progesterone levels fluctuate with pulsatile LH release over several hours — makes single-value interpretation unreliable

Current Guidelines

ASRM Committee Opinion 2015, reaffirmed 2021: There is "no reproducible, pathophysiologically relevant, and clinically practical standard" to diagnose LPD and distinguish fertile from infertile women. ESHRE agrees. → Screening and treating for LPD are NOT recommended in women with RPL.

Progesterone Supplementation in RPL

• 2018 Cochrane review (12 trials, 1856 participants): progestogen supplementation may reduce miscarriages vs. placebo (RR 0.73, 95% CI 0.54–1.00)
• 2021 Cochrane review: women with first-trimester bleeding + RPL may benefit from vaginal progesterone
• However, a large RCT showed progesterone at time of positive pregnancy test was not beneficial in women with RPL without bleeding
• Progesterone is NOT a proven treatment for newly pregnant women with RPL in general

---

📙 3. Robbins & Kumar Basic Pathology

• LPD is listed as a less common cause of dysfunctional uterine bleeding (DUB)
• Described as resulting from insufficient production of progesterone by the corpus luteum
• Most common cause of DUB remains anovulation; LPD represents the inadequate luteal phase subtype
• DUB = uterine bleeding lacking an underlying structural abnormality

---

📕 4. Robbins, Cotran & Kumar — Pathologic Basis of Disease

• LPD listed as a maternal endocrine cause of spontaneous abortion
• Listed alongside poorly controlled diabetes and other endocrine disorders
• Context: 10–15% of clinically recognized pregnancies → spontaneous abortion; 50% caused by fetal chromosomal anomalies; LPD is among the maternal endocrine contributors

---

📔 5. Tietz Textbook of Laboratory Medicine

Classification

• LPD categorized under hypergonadotropic hypogonadism as a cause of female infertility
• Listed alongside: primary ovarian insufficiency, gonadal dysgenesis, resistant ovary syndrome, menopause

Current Definition

Historically: ovulation with inadequate luteinization and reduced progesterone secretion. Currently defined as: luteal phase length < 10 days between ovulation and menses, OR < 13 days between LH surge and menses.

Presumed Mechanism

• Decreased progesterone production — may follow:
  • Insufficient follicular phase FSH secretion
  • Abnormal LH surge
  • Other endocrine abnormalities

Diagnosis — Lab Perspective

• Historically: serum progesterone measurement or endometrial biopsy
• Currently: clinical diagnosis defined by luteal phase length
• The clinical significance remains unclear

Treatment

• Clomiphene citrate or aromatase inhibitors early in the follicular phase — to improve follicular recruitment and subsequent luteal function
• Progesterone supplementation in the luteal phase

---

🔑 Cross-Book Consensus Summary